Organophosphate poisoning: muscarinic vs nicotinic signs
One poison, two halves of the picture, two antidotes. Learn the muscarinic and nicotinic features of organophosphate poisoning and how atropine and pralidoxime work.
Chapters (12)
Explain the muscarinic and nicotinic features of acetylcholinesterase-inhibitor (organophosphate) poisoning and the mechanisms of atropine and pralidoxime.
The short version
- Organophosphates inactivate acetylcholinesterase, so acetylcholine floods muscarinic, nicotinic and central receptors.
- Muscarinic signs follow D U M B B E L S, plus sweating; the mnemonic covers only the muscarinic half.
- Atropine, a competitive muscarinic antagonist, treats the muscarinic signs but not nicotinic weakness.
- Pralidoxime reactivates the enzyme and treats the weakness, but only before the enzyme ages.
- Most deaths come from respiratory failure: flooded airways plus weak breathing muscles.
Organophosphate poisoning: one poison, two antidotes
A farm worker is found slumped beside a sprayer, drenched in sweat. His pupils are tiny, he is drooling, his chest is wet with secretions and his muscles are twitching.
Organophosphate poisoning explains all of it. This lesson separates the muscarinic and nicotinic features and shows why one antidote fixes one half of the picture and a second antidote is needed for the other.[1][2]
Normal transmission: acetylcholine and acetylcholinesterase
Normally, acetylcholine is released, binds its receptors, and is rapidly broken down by acetylcholinesterase in the synaptic cleft.[1][2]
It acts on two receptor families:[2][4]
- Muscarinic receptors sit on glands, smooth muscle and the heart.
- Nicotinic receptors sit at the neuromuscular junction and in the autonomic ganglia.
How organophosphates inactivate the enzyme
Organophosphates, found in insecticides and in nerve agents such as sarin, bind to the enzyme's active site, phosphorylate its serine and inactivate it.[3][4]
Acetylcholine therefore piles up at every cholinergic synapse, and every receptor is overstimulated: muscarinic, nicotinic and central.[2][3]
Muscarinic vs nicotinic signs, and the DUMBBELS mnemonic
The muscarinic effects come first: diarrhea, urination, miosis, bronchorrhea, bradycardia, emesis, lacrimation and salivation. Sweating joins them.[1][2][3]
| Receptor type | Where | Features |
|---|---|---|
| Muscarinic | Glands, smooth muscle, heart; also sweat glands (sympathetic fibres, muscarinic receptors) | D U M B B E L S, plus sweating |
| Nicotinic | Neuromuscular junction | Fasciculations, then weakness and paralysis, including the breathing muscles |
| Nicotinic | Autonomic ganglia | Can raise heart rate and blood pressure |
| Central | Brain | Confusion, seizures, coma |
The nicotinic effects at the neuromuscular junction are twitching, called fasciculations, then weakness and paralysis.[1][2] At the ganglia, nicotinic stimulation can even raise the heart rate and blood pressure.[2]
In the brain, the excess causes confusion, seizures and coma.[1][2]
Most deaths come from respiratory failure: airways flooded with secretions, and muscles too weak to breathe. Both halves of the picture contribute, which is why both need treating.[1][2]
Antidote one: atropine
Atropine is a competitive muscarinic antagonist. It blocks the muscarinic receptors, so the secretions dry up, the airways clear and the heart rate recovers.[1][2][3]
Doses are repeated until the chest is clear of secretions and wheeze, the bedside endpoint taught here; studies also track pupils, pulse and flushing.[5]
But atropine does not touch nicotinic receptors, so the twitching and weakness remain.[2][7]
A quick check on two signs:
| Sign | Receptor type | Does atropine help? |
|---|---|---|
| Twitching thigh | Nicotinic | No |
| Drooling | Muscarinic | Yes |
A twitching thigh is nicotinic, so atropine will not help. Drooling is muscarinic, so atropine will help.[2][7]
Antidote two: pralidoxime and the aging deadline
Pralidoxime is an oxime. It binds the enzyme, pulls the phosphate off the serine and regenerates working acetylcholinesterase.[4][6][7]
That restores transmission at the neuromuscular junction, so it treats the weakness that atropine cannot.[3][7]
Only works before aging, when the enzyme-phosphate bond becomes permanent.
There is a deadline. With time, the phosphorylated enzyme ages: a chemical change makes the bond permanent, and pralidoxime can no longer reverse it.[4][7]
Pralidoxime barely enters the brain, and seizures are treated with a benzodiazepine.[3][6][7]
Whether pralidoxime improves survival in trials is still debated, but the mechanism is the high-yield part.[2][6][7]
Organophosphate poisoning: putting it together
- The poisonOrganophosphates inactivate cholinesterase, so acetylcholine floods muscarinic, nicotinic and central receptors.[3][4]
- AtropineIt treats the muscarinic signs; it does not treat nicotinic weakness.[2][7]
- PralidoximeIt reactivates the enzyme, and only before the enzyme ages.[4][7]
Matching each sign to its receptor type is what tells you which antidote it needs.[2][7]
Practice question
Original · USMLE styleA 38-year-old woman is brought to the emergency department after a pesticide spill while she was working in a cotton field. She is sweating, drooling and wheezing. Pulse is 48/min, blood pressure is 96/58 mm Hg, and pupils are 1 mm bilaterally. Fasciculations are visible in her thigh muscles. After intravenous atropine, her secretions dry and her pulse rises to 88/min. The fasciculations continue, and she now has difficulty lifting her arms and holding up her head.
Common questions
What are the muscarinic signs of organophosphate poisoning?
Diarrhea, urination, miosis, bronchorrhea, bradycardia, emesis, lacrimation and salivation (D U M B B E L S), plus sweating. The mnemonic describes only the muscarinic half.
Why does atropine not fix muscle weakness in organophosphate poisoning?
Atropine is a competitive muscarinic antagonist. The weakness is a nicotinic effect at the neuromuscular junction, and atropine does not touch nicotinic receptors.
How does pralidoxime work?
It binds the enzyme, pulls the phosphate off the serine and regenerates working acetylcholinesterase, which restores transmission at the neuromuscular junction. It works only before the enzyme ages.
What is aging of acetylcholinesterase?
With time, a chemical change makes the bond between the phosphate and the enzyme permanent, and pralidoxime can no longer reverse it.
What causes death in organophosphate poisoning?
Most deaths come from respiratory failure: airways flooded with secretions, and muscles too weak to breathe.
Transcript
Read the full narration, by chapter658 words
0:00The case: one poison, two antidotes
A farm worker is found slumped beside a sprayer, drenched in sweat. His pupils are tiny, he is drooling, his chest is wet with secretions, and his muscles are twitching. One poison explains all of it, and two antidotes fix two different halves of the picture. How? Today: the muscarinic and nicotinic features of cholinesterase poisoning, and how atropine and pralidoxime work.
0:25Normal transmission: acetylcholine, acetylcholinesterase, two receptor families
Normally, acetylcholine is released, binds its receptors, and is rapidly broken down by acetylcholinesterase in the synaptic cleft. It acts on two receptor families. Muscarinic receptors sit on glands, smooth muscle and the heart. Nicotinic receptors sit at the neuromuscular junction and in the autonomic ganglia.
0:48How organophosphates inactivate the enzyme
Organophosphates, found in insecticides and in nerve agents such as sarin, bind to the enzyme's active site, phosphorylate its serine, and inactivate it. So acetylcholine piles up at every cholinergic synapse, and every receptor is overstimulated. The muscarinic effects come first:
1:06Muscarinic effects and the D U M B B E L S mnemonic
diarrhea, urination, miosis, bronchorrhea, bradycardia, emesis, lacrimation and salivation. Sweating joins them. The mnemonic is DUMBBELS, and it describes only the muscarinic half. The nicotinic effects come at the neuromuscular
1:25Nicotinic effects, central effects and respiratory failure
junction: twitching, called fasciculations, then weakness and paralysis, including the breathing muscles. At the ganglia, nicotinic stimulation can even raise the heart rate and blood pressure, so a fast pulse does not exclude this poisoning. In the brain, the excess causes confusion, seizures and coma. Most deaths come from respiratory failure: airways flooded with secretions, and muscles too weak to breathe. Antidote one is atropine,
1:56Antidote one: atropine
a competitive muscarinic antagonist. It blocks the muscarinic receptors, so the secretions dry up, the airways clear and the heart rate recovers. Doses are repeated until the chest is clear of secretions and wheeze. But atropine does not touch nicotinic receptors, so the twitching and weakness remain.
2:19Antidote two: pralidoxime
Antidote two is pralidoxime, an oxime. It binds the enzyme, pulls the phosphate off the serine, and regenerates working acetylcholinesterase. That restores transmission at the neuromuscular junction, so it treats the weakness that atropine cannot.
2:37The deadline: aging, brain entry and the evidence
There is a deadline. With time, the phosphorylated enzyme ages: a chemical change makes the bond permanent, and pralidoxime can no longer reverse it. Pralidoxime barely enters the brain, and seizures are treated with a benzodiazepine. Whether it improves survival in trials is still debated, but the mechanism is the high-yield part.
3:01Quick check
Quick check. A twitching thigh: nicotinic, atropine will not help. Drooling: muscarinic, atropine will help.
3:12Your turn: a practice question
Your turn. A 38-year-old woman is brought in after a pesticide spill in a cotton field. She is sweating, drooling and wheezing. Her pulse is 48 a minute, blood pressure 96 over 58, and her pupils are one millimetre. Fasciculations are visible in her thigh muscles. After intravenous atropine, her secretions dry and her pulse rises to 88. But the fasciculations continue, and she now struggles to lift her arms or hold up her head. Which of the following best explains the persistent weakness and names the drug that addresses it? A, muscarinic overstimulation of skeletal muscle; higher-dose atropine. B, nicotinic overstimulation at the neuromuscular junction; pralidoxime. C, atropine blockade of neuromuscular nicotinic receptors; neostigmine. D, central nervous system cholinergic excess; physostigmine. E, depletion of acetylcholine in the motor nerve terminal; edrophonium.
4:20Decide, then the options one at a time
Pause here and decide. A is out: skeletal muscle uses nicotinic receptors, so more atropine will not help. C is out: atropine blocks muscarinic receptors, not the neuromuscular ones, and neostigmine would add more acetylcholine. D is out: the weakness is peripheral, and physostigmine inhibits cholinesterase, which is the problem we already have. E is out: acetylcholine is not depleted here, it is in excess, and edrophonium would worsen that. So the answer is B. Persistent weakness after atropine is nicotinic, and pralidoxime reactivates the enzyme at the neuromuscular junction.
5:06Recap pocket card and next lesson
Three things to keep. One: organophosphates inactivate cholinesterase, so acetylcholine floods muscarinic, nicotinic and central receptors. Two: atropine treats the muscarinic signs; it does not treat nicotinic weakness. Three: pralidoxime reactivates the enzyme, and only before it ages. Next, receptor desensitization and upregulation.
Sources
Numbers in the text, e.g. [1], point here- Organophosphate poisoning. Wikipedia. en.wikipedia.org/wiki/Organophosphate_poisoning
- Clinical features of organophosphorus poisoning. PMC4238091. pmc.ncbi.nlm.nih.gov/articles/PMC4238091/
- LITFL. Organophosphate poisoning. litfl.com/organophosphate-poisoning/
- Organophosphorus pesticide review. PMC12557714. pmc.ncbi.nlm.nih.gov/articles/PMC12557714/
- Atropinisation in organophosphate poisoning. PMC12616316. pmc.ncbi.nlm.nih.gov/articles/PMC12616316/
- Oxime reactivators of cholinesterase. PMC6547910. pmc.ncbi.nlm.nih.gov/articles/PMC6547910/
- Pralidoxime. Wikipedia. en.wikipedia.org/wiki/Pralidoxime
- Cholinesterase inhibitors (neostigmine, physostigmine, edrophonium). PMC10019356 and PMC9772266. pmc.ncbi.nlm.nih.gov/articles/PMC10019356/ · pmc.ncbi.nlm.nih.gov/articles/PMC9772266/
The practice question is original and its patient is synthetic. Every fact is checked against the sources above in independent accuracy reviews. Always follow your local guidelines and your own laboratory’s ranges.
Image credits. Illustrations: Servier Medical Art (smart.servier.com), CC BY 4.0 (https://creativecommons.org/licenses/by/4.0/), adapted (recoloured, outlined, resized): eye, salivary glands, bronchus, muscle, neuromuscular synapse (two plates), intestine, bladder, heart, tear duct, brain, syringe. Sweat gland: NIAID NIH BioArt (public domain). Farmer icon: Health Icons (CC0). The sprayer, enzyme, phosphate, atropine key, pralidoxime capsule, aging sequence, stomach, ganglion sketch, cards and all handwriting are drawn in code (original schematics). No AI-generated teaching images.
Corrections. None so far. Spotted an error? Email info@medservatory.com with the lesson code MS-S1-PHARM-014.
For exam study only, not medical advice. Read the medical disclaimer.
In this series
Playlist on YouTube- EP 01Potency vs efficacy: EC50, Emax and agonist types5:17
- EP 02Competitive vs noncompetitive antagonists: effect on EC50 and Emax5:01
- EP 03Therapeutic index explained: TD50 / ED505:01
- EP 04First-pass metabolism and bioavailability: calculating oral F from AUC5:18
- EP 05Volume of distribution: why Vd can be bigger than the body5:17
- EP 06Clearance and half-life: t½ = 0.693 × Vd / CL5:01
- EP 07Zero-order vs first-order elimination explained5:12
- EP 08Loading dose and maintenance dose, explained5:02
- EP 09CYP450 inducers and inhibitors: how they change drug levels5:16
- EP 10Autonomic receptors: alpha, beta and muscarinic5:33
- EP 11Beta blocker selectivity: beta-1, ISA and alpha blockade5:24
- EP 12Vasopressors compared: receptors, pressure and heart rate5:46
- EP 13Organophosphate poisoning: muscarinic vs nicotinic signs5:36
- EP 14Receptor desensitization, downregulation and upregulation5:01
- EP 15Beta-lactams and vancomycin: enzyme versus substrate5:04
- EP 16Protein synthesis inhibitors: 30S vs 50S antibiotics5:07